4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-000482
Chief Executive Officer gave up 10,796 shares (to pay taxes)
- Chief Executive Officer acquired 31,198 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Robinson Chandler · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-31 | Exercise or conversion : show line 1 in the form | +24,474 | 152,900.8 | D | ||
| 2023-12-31 | Shares withheld for taxes : show line 2 in the form | −8,469 | $0.34 | $2,881 | 144,431.8 | D |
| 2024-01-01 | Exercise or conversion : show line 3 in the form | +6,724 | 151,155.8 | D | ||
| 2024-01-01 | Shares withheld for taxes : show line 4 in the form | −2,327 | $0.34 | $792 | 148,828.8 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-31 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −24,474 | 229,009 | D |
| 2024-01-01 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −6,724 | 222,285 | D |
Loading xslF345X05/rdgdoc.xml…